Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, January 13, 2019

Limits to human neurogenesis—really?

It is your doctors' responsibility to give you EXACT protocols on how to accomplish neurogenesis to get to 100% recovery. Not your responsibility to figure this out unless your doctor is incompetent in getting you 100% recovered.  There better not be any limits. I need to replace approximately 5.571 billion dead neurons. WHERE ARE MY INSTRUCTIONS?

Limits to human neurogenesis—really?

Molecular Psychiatry (2019) | Download Citation

Access options


Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
Rent or Buy
All prices are NET prices.


Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Sorrells SF, Paredes MF, Cebrian-Silla A, Sandoval K, Qi D, Kelley KW, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555:377–81.


  • 2.
    Bao A-M, Swaab DF. The art of matching brain tissue from patients and controls for postmortem research. Handb Clin Neurol. 2018;150:197–217.

  • 3.
    Gonzalez-Riano C, Tapia-González S, García A, Muñoz A, DeFelipe J, Barbas C. Metabolomics and neuroanatomical evaluation of post-mortem changes in the hippocampus. Brain Struct Funct. 2017;222:2831–53.
  • 4.
    Boekhoorn K, Joels M, Lucassen PJ. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis. 2006;24:1–14.
  • 5.
    Blair JA, Wang C, Hernandez D, Siedlak SL, Rodgers MS, Achar RK, et al. Individual case analysis of postmortem interval time on brain tissue preservation. PLoS ONE. 2016;11:e0151615.
  • 6.
    Sumida M, Hane M, Yabe U, Shimoda Y, Pearce OM, Kiso M, et al. Rapid trimming of cell surface polysialic acid (PolySia) by exovesicular sialidase triggers release of preexisting surface neurotrophin. J Biol Chem. 2015;290:13202–14.
  • 7.
    Ryan SM, Nolan YM. Neuroinflammation negatively affects adult hippocampal neurogenesis and cognition: can exercise compensate? Neurosci Biobehav Rev. 2016;61:121–31.
  • 8.
    Lucassen PJ, Oomen CA, Naninck EF, Fitzsimons CP, van Dam AM, Czeh B, et al. Regulation of adult neurogenesis and plasticity by (early)stress, glucocorticoids, and inflammation. Cold Spring Harb Perspect Biol. 2015;7:a021303.
  • 9.
    Chawana R, Alagaili A, Patzke N, Spocter MA, Mohammed OB, Kaswera C, et al. Microbats appear to have adult hippocampal neurogenesis, but post-capture stress causes a rapid decline in the number of neurons expressing doublecortin. Neuroscience. 2014;277:724–33.
  • 10.
    Amrein I, Dechmann DK, Winter Y, Lipp HP. Absent or low rate of adult neurogenesis in the hippocampus of bats (Chiroptera). PLoS ONE. 2007;2:e455.
  • 11.
    Erkut ZA, Klooker T, Endert E, Huitinga I, Swaab DF. Stress of dying is not suppressed by high-dose morphine or by dementia. Neuropsychopharm. 2004;29:152–7.
  • 12.
    Boldrini M, Fulmore CA, Tartt AN, Simeon LR, Pavlova I, Poposka V, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589–99.
  • 13.
    Jessberger S, Parent JM. Epilepsy and adult neurogenesis. Cold Spring Harb Perspect Biol. 2015;7:a020677.
  • 14.
    Verwer RW, Sluiter AA, Balesar RA, Baayen JC, Speijer D, Idema S, et al. Altered loyalties of neuronal markers in cultured slices of resected human brain tissue. Brain Pathol. 2016;26:523–32.
  • 15.
    Wu MV, Sahay A, Duman RS, Hen R. Functional differentiation of adult-born neurons along the septotemporal axis of the dentate gyrus. Cold Spring Harb Perspect Biol. 2015;7:a018978.
  • 16.
    Puyal J, Ginet V, Clarke PG. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection. Prog Neurobiol. 2013;105:24–48.
  • 17.
    Kempermann G, Gage FH, Aigner L, Song H, Curtis MA, Thuret S, et al. Human adult neurogenesis: evidence and remaining questions. Cell Stem Cell. 2018;S1934-5909:30166–8.
  • 18.
    Paredes MF, Sorrells SF, Cebrian-Silla A, Sandoval K, Qi D, Kelley KW, et al. Does Adult Neurogenesis Persist in the Human Hippocampus? Cell Stem Cell. 2018;23:780–1.
  • 19.
    Tartt AN, Fulmore CA, Liu Y, Rosoklija GB, Dwork AJ, Arango V, et al. Considerations for Assessing the Extent of Hippocampal Neurogenesis in the Adult and Aging Human Brain. Cell Stem Cell. 23:782–3.

    • Author information

    Affiliations

    1. Brain Plasticity Group, Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, The Netherlands

      • Paul J. Lucassen

    2. Lausanne University Hospital, Department of Psychiatry, Center for Psychiatric Neurosciences, Lausanne, Switzerland

      • Nicolas Toni

    3. German Center for Neurodegenerative Diseases (DZNE) Dresden, and CRTD—Center for Regenerative Therapies Dresden, Technische Universität, Dresden, Germany

      • Gerd Kempermann

    4. Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden

      • Jonas Frisen

    5. Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA

      • Fred H. Gage

    6. Netherlands Institute for Neurosciences, Meibergdreef, Amsterdam, The Netherlands

      • Dick F. Swaab

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Corresponding author

    Correspondence to Paul J. Lucassen.
    To obtain permission to re-use content from this article visit RightsLink.

    About this article

    Publication history

    Received

    Accepted

    Published

    DOI

    https://doi.org/10.1038/s41380-018-0337-

    Posted by at
    Labels: , , , ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)